Archives

  • 2018-07
  • 2018-10
  • 2018-11
  • 2019-04
  • 2019-05
  • 2019-06
  • 2019-07
  • 2019-08
  • 2019-09
  • 2019-10
  • 2019-11
  • 2019-12
  • 2020-01
  • 2020-02
  • 2020-03
  • 2020-04
  • 2020-05
  • 2020-06
  • 2020-07
  • 2020-08
  • 2020-09
  • 2020-10
  • 2020-11
  • 2020-12
  • 2021-01
  • 2021-02
  • 2021-03
  • 2021-04
  • 2021-05
  • 2021-06
  • 2021-07
  • 2021-08
  • 2021-09
  • 2021-10
  • 2021-11
  • 2021-12
  • 2022-01
  • 2022-02
  • 2022-03
  • 2022-04
  • 2022-05
  • 2022-06
  • 2022-07
  • 2022-08
  • 2022-09
  • 2022-10
  • 2022-11
  • 2022-12
  • 2023-01
  • 2023-02
  • 2023-03
  • 2023-04
  • 2023-05
  • 2023-06
  • 2023-07
  • 2023-08
  • 2023-09
  • 2023-10
  • 2023-11
  • 2023-12
  • 2024-01
  • 2024-02
  • 2024-03
  • 2024-04
  • 2024-05
  • As a potential therapeutic target

    2018-11-05

    As a potential therapeutic target, the pleiotropic actions of prolactin engender both excitement and frustration. Excitement, because clear beneficial actions shown in the lab seem to have huge potential for developing new treatments. Frustration, because with so many other tissues possibly influenced by prolactin, it might be difficult to target effects specifically to the tissue of interest (). Nevertheless, it seems inevitable that studies such as these are bringing us closer to harnessing the potential of this multifunctional molecule, and I look forward with interest to further developments coming from this group of researchers, and others stimulated by their findings. Conflicts of interest
    We commend for examining child stunting in the context of protein and amino acids, which, beyond supplying essential nitrogen for protein synthesis, are involved in regulation of linear growth, an issue that has not been addressed sufficiently. The authors reported significant associations between low levels of serum amino acids and stunting in a cross-sectional study of young children in rural Malawi. As the authors note, studies of micronutrient and lipid supplements have failed to demonstrate improved linear growth in malnourished children. Furthermore, the ten most effective interventions recommended for scale up at the global level are likely to reduce stunting by only ~20% even at a coverage level of 90% (). Thus, we are writing to comment on the findings of Semba et al., highlight relevant past and current research and advocate for further collaborative effort forward in the area of protein quality and childhood stunting. The results of Semba et al. raise a number of questions, including the interpretation of circulating amino acids. Plasma concentrations are static, representing the net effect of changes in production and utilization of an amino acid, unlike the dynamic flux. For example, plasma citrulline flux, which indicates enterocyte mass and function, is not reflected in its plasma concentration (). Thus, among stunted children, are low circulating amino acids a biomarker of recent protein intake, the body\'s amino acid pool, acute protein deficiency, or simply a reflection of short-term physiological processes such as digestion and nae inhibitor ()? Or do the levels of circulating amino acids represent a response to entirely different biological processes such as presence of infection () or a metabolic adjustment to preserve nutrients critical for maintaining lean body mass during periods of low intake of quality protein? What is clear from the novel approach used by Semba et al. is that physiological outcomes such as stunting and nutritional factors such as protein and amino acids and their metabolism and turnover are complex phenomena, and additional research will be required to answer these questions. While the emphasis from protein shifted to energy and micronutrients in the late 1970\'s, as noted by Semba et al., it was by no means an end to the work on protein quality; we would be remiss not to mention the decades of seminal work conducted since then through the leadership of the late Drs. Nevin Scrimshaw and Vernon Young. This included elucidating the relationship of protein and energy interactions, redefining protein and amino acid requirements within the context of high and low energy availabilities, and investigating the health impacts from improving protein quality via increased intake of essential amino acids (EAAs)—especially lysine, the most limiting EAA in cereal based diets. Dr. Scrimshaw\'s seminal protein work has continued through the nae inhibitor Nevin Scrimshaw International Nutrition Foundation, which co-organized a workshop on the topic of protein quality and growth in 2012 (). One reason that protein and amino acids are often overlooked in relation to stunting may be that while children in low-resource, developing country contexts appear to have adequate protein intake; however, there are two issues that may, in fact, put them at risk of inadequacy. First, failure to adjust for protein quality—a composite of the EAA profile as compared to the requirement pattern, and the “digestibility”, or absorption and utilization of the amino acids in foods, both of which can decrease the effective protein available to the body—results in overestimates of dietary protein adequacy. Second, the needs of children in these contexts are systematically underestimated; current protein and amino acid requirements do not account for conditions of energy deficit, and persistent or subclinical infections, which could be compounded by sub-optimal digestive and absorptive intestinal function; emerging research also suggests a connection with the microbiome ().